169 related articles for article (PubMed ID: 33559731)
1. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.
Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
Gen Thorac Cardiovasc Surg; 2019 Nov; 67(11):949-954. PubMed ID: 30972530
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
[TBL] [Abstract][Full Text] [Related]
5. Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer.
Shinohara S; Otsuki R; Kobayashi K; Sugaya M; Matsuo M; Nakagawa M
Ann Surg Oncol; 2020 Jul; 27(7):2427-2435. PubMed ID: 31970570
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.
Kim EY; Lee HY; Kim KW; Lee JI; Kim YS; Choi WJ; Kim JH
Scand J Surg; 2018 Sep; 107(3):244-251. PubMed ID: 29284364
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
[TBL] [Abstract][Full Text] [Related]
9. Classification based on skeletal muscle mass and the severity of lung emphysema impacts on clinical outcomes after anatomical resection for lung cancer.
Tsubokawa N; Mimura T; Tadokoro K; Yamashita Y
Jpn J Clin Oncol; 2022 Aug; 52(8):917-924. PubMed ID: 35438159
[TBL] [Abstract][Full Text] [Related]
10. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
Nakada T; Noda Y; Kato D; Shibasaki T; Mori S; Asano H; Matsudaira H; Hirano J; Odaka M; Ohtsuka T
Thorac Cancer; 2019 Oct; 10(10):1945-1952. PubMed ID: 31436042
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.
Tsukioka T; Nishiyama N; Izumi N; Mizuguchi S; Komatsu H; Okada S; Toda M; Hara K; Ito R; Shibata T
Jpn J Clin Oncol; 2017 Apr; 47(4):363-368. PubMed ID: 28158497
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
[TBL] [Abstract][Full Text] [Related]
17. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
Sato S; Sato M; Shinohara H
Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
Ushitani Y; Shimada Y; Yamada Y; Kudo Y; Yamada T; Tanaka T; Ohira T; Ikeda N
Ann Surg Oncol; 2022 Oct; 29(11):6922-6931. PubMed ID: 35729292
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer.
Huang DD; Wang SL; Zhuang CL; Zheng BS; Lu JX; Chen FF; Zhou CJ; Shen X; Yu Z
Colorectal Dis; 2015 Nov; 17(11):O256-64. PubMed ID: 26194849
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
